These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8586759)

  • 41. Combination of PUVAsol and topical calcipotriol in vitiligo.
    Parsad D; Saini R; Verma N
    Dermatology; 1998; 197(2):167-70. PubMed ID: 9732168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival.
    Kim NH; Lee AY
    Exp Dermatol; 2010 Dec; 19(12):1073-9. PubMed ID: 21054556
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-cell responses against 4-tert-butylphenol-exposed pigmented cells in a patient with occupational vitiligo.
    Vrijman C; Willemsen KJ; Tjin EPM; Kammeyer A; van den Boorn JG; van der Veen JPW; Jungbauer FHW; Kardaun SH; Luiten RM
    Br J Dermatol; 2019 Aug; 181(2):387-388. PubMed ID: 30719700
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo.
    Kumaran MS; Kaur I; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):269-73. PubMed ID: 16503885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Systematic understanding the mechanisms of vitiligo pathogenesis and its treatment by Qubaibabuqi formula.
    Pei T; Zheng C; Huang C; Chen X; Guo Z; Fu Y; Liu J; Wang Y
    J Ethnopharmacol; 2016 Aug; 190():272-87. PubMed ID: 27265513
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Melanin and melanosome complexes in long standing stable vitiligo--an ultrastructural study.
    Bartosik J; Wulf HC; Kobayasi T
    Eur J Dermatol; 1998 Mar; 8(2):95-7. PubMed ID: 9649719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral trimethylpsoralen in the treatment of vitiligo.
    Theodoridis A; Tsambaos D; Sivenas C; Capetanakis J
    Acta Derm Venereol; 1976; 56(3):253-6. PubMed ID: 59512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of oral androstenedione administration on serum testosterone and estradiol levels in postmenopausal women.
    Leder BZ; Leblanc KM; Longcope C; Lee H; Catlin DH; Finkelstein JS
    J Clin Endocrinol Metab; 2002 Dec; 87(12):5449-54. PubMed ID: 12466335
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Immunohistopathological analysis of frizzled-4-positive immature melanocytes from hair follicles of patients with Rhododenol-induced leukoderma.
    Okamura K; Ohe R; Abe Y; Ueki M; Hozumi Y; Tamiya G; Matsunaga K; Yamakawa M; Suzuki T
    J Dermatol Sci; 2015 Nov; 80(2):156-8. PubMed ID: 26277630
    [No Abstract]   [Full Text] [Related]  

  • 51. PUVA-induced repigmentation of vitiligo: scanning electron microscopy of hair follicles.
    Ortonne JP; Schmitt D; Thivolet J
    J Invest Dermatol; 1980 Jan; 74(1):40-2. PubMed ID: 7351492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunolocalization of tenascin-C in vitiligo.
    Abdou AG; Maraee AH; Shoeib MA; Elbana R
    Appl Immunohistochem Mol Morphol; 2012 Oct; 20(5):501-11. PubMed ID: 22495383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pimecrolimus cream in repigmentation of vitiligo.
    Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
    Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Validation study of the Vitiligo Extent Score-plus.
    van Geel N; Wolkerstorfer A; Lommerts JE; Ezzedine K; Eleftheriadou V; Hamzavi I; Harris J; Picardo M; Taieb A; Prinsen CAC; Bekkenk M; Speeckaert R
    J Am Acad Dermatol; 2018 May; 78(5):1013-1015. PubMed ID: 29180094
    [No Abstract]   [Full Text] [Related]  

  • 55. IL-17 induces cellular stress microenvironment of melanocytes to promote autophagic cell apoptosis in vitiligo.
    Zhou J; An X; Dong J; Wang Y; Zhong H; Duan L; Ling J; Ping F; Shang J
    FASEB J; 2018 Sep; 32(9):4899-4916. PubMed ID: 29613836
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eruptive cherry angiomas associated with vitiligo: provoked by topical nitrogen mustard?
    Ma HJ; Zhao G; Shi F; Wang YX
    J Dermatol; 2006 Dec; 33(12):877-9. PubMed ID: 17169094
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitiligo: an update on current pharmacotherapy and future directions.
    Colucci R; Lotti T; Moretti S
    Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vitiligo treatment.
    Ortel B; Tanew A; Hönigsmann H
    Curr Probl Dermatol; 1986; 15():265-71. PubMed ID: 3948525
    [No Abstract]   [Full Text] [Related]  

  • 59. [Studies on the follicular melanocytes in the repigmented area of vitiligo after PUVA treatment (author's transl)].
    Fukuda S
    Nihon Hifuka Gakkai Zasshi; 1979 Apr; 89(5):355-67. PubMed ID: 313465
    [No Abstract]   [Full Text] [Related]  

  • 60. The Vitiligo Extent Score (VES) and the VESplus are responsive instruments to assess global and regional treatment response in patients with vitiligo.
    van Geel N; Bekkenk M; Lommerts JE; Ezzedine K; Harris J; Hamzavi I; Eleftheriadou V; Picardo M; Taieb A; Prinsen CAC; Wolkerstorfer A; Speeckaert R
    J Am Acad Dermatol; 2018 Aug; 79(2):369-371. PubMed ID: 29307645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.